ENANTA PHARMACEUTICALS INC - Common Stock (ENTA)

CUSIP: 29251M106

Q2 2020 13F Holders as of 30 Jun 2020

Security identity
Security type / class
Equity / Common Stock
Shares outstanding
28,862,345
Holder snapshot
Total 13F shares
18,268,221
Share change
+235,219
Total reported value
$917,098,781
Put/Call ratio
634%
Reported price per share
$50.21
Number of holders
173
Value change
+$10,521,228
Number of buys
95
Number of sells
66

Security key

29251M106

Report period

Q2 2020

Institutions

173

Top holders

10

ENTA full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2020 Previous quarter: Q1 2020 ENANTA PHARMACEUTICALS INC SEC filings ENANTA PHARMACEUTICALS INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ENTA - ENANTA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
BlackRock Finance, Inc.
13D/G signal
—
Evidence rows
15
Latest as of
31 Mar 2020
13F Lead comparable stake: 9.8% Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
9.8%
$145,646,000
2,831,898 shares
 — 31 Mar 2020
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
13F
6.1%
$90,003,000
1,750,000 shares
 — 31 Mar 2020
VANGUARD GROUP INC
13F
Company
13F
5.9%
$86,930,000
1,690,260 shares
 — 31 Mar 2020
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
4.7%
$69,684,000
1,354,938 shares
 — 31 Mar 2020
STATE STREET CORP
13F
Company
13F
3.1%
$46,695,000
907,924 shares
 — 31 Mar 2020
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
3.1%
$45,289,000
880,600 shares
 — 31 Mar 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
173
Shares
18,268,221
Rows available
173
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
154
Q2 2020 holders
173
Holder diff
19
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 value Q2 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .